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ABSTRACT

The purpose of this study was to determine whether the implementation of
a stroke clinical pathway could improve compliance with documentation of
specific quality measures for patients admitted with the diagnosis of acute
ischemic stroke, hemorrhagic stroke, or transient ischemic attack. The study
used the ten standardized performance measures for stroke identified by the
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and
integrated documentation of those measures into a stroke clinical pathway
consisting of physician order sets, an interdisciplinary plan of care, and a
patient/family education flow sheet. The American Stroke Association’s Get with
the Guidelines – Stroke (GWTG-Stroke) database was used to collect data
retrospectively on 220 patient records. The control group consisted of 110
randomly selected records of patients admitted with stroke in the year prior to
clinical pathway implementation. The intervention group consisted of 110
consecutive records for patients discharged with a stroke diagnosis six months
after clinical pathway implementation. Six data collectors reviewed the records to
gather the information. Records were entered into the database by a single
researcher. A pre-defined measure report was prepared for the “JCAHO Pilot-10”
from the GWTG-Stroke database. Comparison of the control and intervention
groups using the Fisher’s Exact test and 95% confidence intervals revealed
statistically significantly higher rates of compliance with the patient/family stroke
education (p<0.001) and smoking cessation counseling (p<0.001) measures after
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pathway implementation. Further analysis of the intervention group was done to
determine if the use of the clinical pathway forms increased documentation
compliance with the measures. There was a statistically significant improvement
in documentation of the measures for the lipid profile (p=0.003) and patient/family
stroke education (p<0.001) measures when at least one form in the clinical
pathway was used. A Chi-square test for linear trend indicated there was a
statistically significant increase in the number of measures met as the usage of
the clinical pathway increased (p<0.001). This study suggests that
implementation of a stroke clinical pathway can improve compliance with
documentation of specific performance measures by members of the healthcare
team.
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CHAPTER I
INTRODUCTION
Stroke is the third leading cause of death in the United States and is the
leading cause of long-term disability. The prevalence of stroke in 2003 was 2.6%
or over five million Americans. About 700,000 of these Americans experienced a
new stroke or a recurrent stroke. About one of every 15 deaths in 2003 could be
attributed to stroke. Death within the first 30 days following stroke occurred in 812% of ischemic stroke victims and 37-38% of hemorrhagic stroke victims. A
transient ischemic attack (TIA) preceded approximately 15% of all strokes. The
estimated cost for stroke care in 2006 was $57.9 billion (Thom et al., 2006).
South Carolina, with its high rate of stroke mortality, is considered part of
the “stroke belt” in the southeastern region of the United States (South Carolina
Department of Health and Environmental Control, 2006). In 2004, stroke was
listed as the fifth most common reason for inpatient hospitalization in South
Carolina for individuals 65 years and older (South Carolina Office of Research &
Statistics, 2005).
A stroke results from the disruption of blood flow through the cerebral
arteries to the brain. The resultant injury, as brain cells die from lack of blood flow
and oxygen, can be devastating and life altering. Ischemic stroke accounts for
88% of all strokes and occurs due to a blockage in a cerebral blood vessel
(Thom et al., 2006). This blockage may be due to plaque or blood clot formation
within the vessel itself. A blockage may also occur when a plaque or clot
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detaches from the inner wall of a blood vessel or is created within the heart and
migrates to a small vessel in the brain where it lodges. Transient ischemic
attacks (TIA) occur from the same mechanism, but the resultant neurologic deficit
is temporary (American Heart Association, Heart and Stroke Facts, 2003). A
focal neurological deficit lasting less than 24 hours has classically been
considered a TIA. The current trend is to consider stroke symptoms a TIA if they
last for less than one hour (Sacco et al., 2006). Hemorrhagic strokes account for
the remaining 12% of strokes (Thom et al., 2006). Since most strokes are
ischemic, recommendations and guidelines for stroke prevention in adults are
primarily directed toward risk factors related to this type of event. Emerging new
therapies for treatment of acute ischemic stroke have raised public and health
care provider’s consciousness. Stroke awareness has since increased across the
nation as well as within the “stroke belt”.
Many guidelines for the management and prevention of stroke, which
have been published and periodically updated, have set a standard of care for
this population (Coull et al., 2002; Adams, Adams, Brott, et al., 2003; Adams,
Adams, Del Zoppo, & Goldstein, 2005; Adams, Del Zoppo, et al., 2007;
Broderick, et al., 2007; Duncan et al., 2005; Sacco et al., 2006; Wolf et al., 1999).
These documents reflect the move toward evidence-based practice in this
country and are intended to assist practitioners in making informed decisions
about disease management (American Heart Association, Stroke Council
Guideline Development Manual, 2006). Yet, the existence of practice guidelines
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alone does not ensure the integration of recommendations into practice by
physicians, nurses and other members of the multidisciplinary team.
Hospitals primarily carry the burden of cost for acute stroke care and
therefore seek strategies for effectively implementing guidelines. The hospital’s
goal is to reduce their cost of stroke care through elimination of unnecessary
tests, procedures, and treatments, while focusing on interventions that are shown
to be more effective for prevention of complications and improvement of
outcomes for the stroke population.
Ten disease-specific care performance measures for stroke were
identified and detailed by Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) in its Disease-Specific Care Certification Program:
Stroke Performance Measurement Implementation Guide (2004) (Table 1).
Inclusion of prompts for ordering and/or documentation of each of those ten
measures into a comprehensive stroke clinical pathway may improve the
incorporation of stroke guidelines into clinical practice.
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Table 1. JCAHO Disease-Specific Care Performance Measures for Stroke
Set Measure
DSC Stroke-1
DSC Stroke-2

Name

DSC Stroke-4A
DSC Stroke-4B
DSC Stroke-5
DSC Stroke-6

Deep vein thrombosis prophylaxis
Discharged on antithrombotics
Patients with atrial fibrillation receiving anticoagulation
therapy
Tissue plasminogen activator (t-PA) considered
Tissue plasminogen activator (t-PA) administered
Antithrombotic medication within 48 hours of hospitalization
Lipid profile

DSC Stroke-7
DSC Stroke-8
DSC Stroke-9
DSC Stroke-10

Screen for dysphagia
Stroke education
Smoking cessation
A plan for rehabilitation was considered

DSC Stroke-3

Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance
Measurement Implementation Guide (2004).

Documentation by the multidisciplinary team of physicians, nurses,
therapists, and others in the patient medical record provides evidence of
incorporation of guidelines into practice. Review of the medical record to
determine compliance with identified measure criteria offers an opportunity for
hospitals to identify areas for process improvement in the care of stroke patients.
Use of standardized order sets or clinical pathways is a JCAHO expectation for
hospitals that seek recognition for excellent stroke patient care (JCAHO,
Disease-Specific Care Toolkit, 2006). The incorporation of such forms, which
follow key practice guidelines, utilize existing documentation processes, and are
readily accessible to all care providers has the potential to positively alter stroke
care.
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Statement of the Problem
The incorporation of elements of the current guidelines into the care and
management of acute stroke patients continues to be a challenge for many
hospitals. Specific performance measures for stroke have been identified and
developed by JCAHO to assist hospitals who are committed to assessing and
improving the processes and quality of stroke care (JCAHO, Performance
Measurement Implementation Guide, 2004). Standardized order sets, clinical
pathways, and nursing care plans are tools that have been utilized by institutions
to meet this goal in the past. Historically, forms such as these have not
consistently proven effective in changing practice as defined by decreased length
of stay and controlled acute care inpatient cost for stroke patients in this
southeastern academic hospital, the site for this study.
Purpose of Study
The purpose of this study is to determine whether the implementation of a
stroke clinical pathway can improve the documentation of the ten JCAHO
disease-specific measures. Clinical pathways are widely accepted as instruments
that aid in the care of patients with a specific disease process, but can be difficult
to introduce into an organization if a significant change in behavior is required of
the users. By tailoring a clinical pathway to current processes in an organization,
use of the documents may increase. Increased utilization of the stroke clinical
pathway would then be expected to increase compliance with the ten measures.
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Hypothesis
Written care protocols such as clinical pathways for the evaluation and
workup of acute ischemic stroke, hemorrhagic stroke, and TIA patients are a
JCAHO disease-specific care expectation (JCAHO, Disease-Specific Care
Toolkit, 2006). The ten JCAHO disease-specific measures for stroke were
identified as evidence-based performance indicators that could improve quality of
care (JCAHO, Performance Measurement Implementation Guide, 2004).
Tracking of compliance with these measures offers hospitals an opportunity to
identify areas for improvement and strategies to affect patient outcomes.
Therefore the following hypothesis is proposed:
•

The use of a stroke clinical pathway will increase compliance with
documentation in the medical record of the ten JCAHO diseasespecific performance measures.
Definitions

The stroke clinical pathway consisted of five separate documents. Those
documents included standardized physician order sets for the emergency
department (Appendix A), inpatient admission (Appendix B), and discharge
(Appendix C), as well as the multidisciplinary forms for documentation of the
patient plan of care (Appendix D) and patient/family education flow sheet
(Appendix E). The patient/family education flow sheet references the
patient/family education handbook which covers each of the topics that should be
discussed with stroke patients and their families (JCAHO, Performance
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Measurement Implementation Guide, 2004). Table 2 lists each of the forms
included in the stroke clinical pathway and denote which of the ten JCAHO
disease-specific measures are addressed by each form.
Table 2. Stroke Clinical Pathway Forms with JCAHO Disease-Specific
Measures
DSC
Inpatient
Emergency
Admission
Stroke
Orders
Orders
Measure
1

Discharge
Orders

X

2
3

X
X

Interdisciplinary
Patient/Family
Education Flow
Sheet

X
X

4A & 4B

Interdisciplinary
Plan of Care

X
X

X

5

X

6

X

7
8

X
X

9
10

X

X

X
X

X

X

X

X

X

X

X

X

The ICD-9-CM Principle Diagnosis Codes for ischemic stroke,
hemorrhagic stroke, and TIA were used to select patient records for review. The
ICD-9-CM stroke codes are listed in Table 3 and the diagnoses for which each of
the ten measures applies are listed in Table 4.
Table 3. ICD-9-CM Principal Diagnosis Codes for Stroke
Ischemic Stroke
433.01

Occlusion and stenosis of basilar artery with cerebral infarction

433.11

Occlusion and stenosis of carotid artery with cerebral infarction

433.21

Occlusion and stenosis of vertebral artery with cerebral infarction
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433.31

Occlusion and stenosis of multiple and bilateral precerebral arteries
with cerebral infarction

433.81

Occlusion and stenosis of other specified precerebral artery with
cerebral infarction

433.91

Occlusion and stenosis of unspecified precerebral artery with cerebral
infarction

434.00

Cerebral thrombosis without mention of cerebral infarction

434.01

Cerebral thrombosis with cerebral infarction

434.11

Cerebral embolism with cerebral infarction

434.91

Cerebral artery occlusion unspecified with cerebral infarction

436

Acute, but ill-defined, cerebrovascular disease

Hemorrhagic Stroke
430
431
432
432.0
432.1
432.9

Subarachnoid hemorrhage
Intracerebral hemorrhage
Other and unspecified intracranial hemorrhage
Non-traumatic extradural hemorrhage
Subdural hemorrhage
Unspecified intracranial hemorrhage

TIA
435.0

Basilar artery syndrome

435.1

Vertebral artery syndrome

435.2
435.3

Subclavian steal syndrome
Vertebrobasilar artery syndrome

435.8

Other specified transient cerebral ischemias

435.9

Unspecified transient cerebral ischemias

Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance
Measurement Implementation Guide (2004)

Table 4. Diagnostic Groups for the JCAHO Pilot-10 Disease-Specific
Measures
DSC Stroke
Ischemic
Hemorrhagic
TIA
Measure
1

X

8

2
3

X
X

X

4A & 4B

X

5
6

X
X

7

X

X

8

X

X

X

9

X

X

X

10

X

X

X
X

Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance
Measurement Implementation Guide (2004)

Anticoagulation therapy included the use of warfarin, heparin or
heparinoids, or other full-dose anticoagulants. Antithrombotic therapy included
the use of aspirin, aspirin/dipyridamole, warfarin, clopidogril, ticlodipine,
unfractionated intravenous heparin, and full dose low molecular-weight heparin.
Thrombolytic therapy included the use of intravenous or intra-arterial
recombinant tissue plasminogen activator (t-PA). Screenings for dysphagia
included documentation of a simple water swallow test or neurological evaluation
specific to swallowing. Stroke education consisted of documentation of patient or
family education related to type of stroke, complications, and secondary
prevention. Smoking cessation counseling included documentation that
information was provided to the patient in addition to advising the patient that
smoking is bad for their health (JCAHO, Performance Measurement
Implementation Guide, 2004; Stroke Coding Instructions v7.2, 2006).
Conceptual Framework
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Lewin’s Force-Field Model of change describes change as occurring when
there is an alteration in the equilibrium of a situation. The change process
consists of three stages. First is “unfreezing” of the status quo, second is
”moving” to a new level of equilibrium, and third is a “refreezing” to the new state
of change (Sullivan & Decker, 2005). Lewin’s model considers the balance of two
types of forces as being responsible for the change process. Those forces are
either driving or restraining forces. The driving force is one that is either away
from a negative or towards a positive situation. The effect of a driving force leads
to locomotion or movement toward change. Obstacles to locomotion due to the
driving force are called restraining forces. Restraining forces do not lead to
locomotion, but influence the effect of the driving forces (Lewin, 1997). In order
to create change, there must be an alteration in the number or degree of
restraining forces and/or driving forces. Once those forces are understood, a
deliberate alteration can result in change. This alteration in forces is the
unfreezing process; the change or movement to the new goal can then take
place. After the change has occurred, a refreezing of the forces in the new
position holds the change in place. A conceptual model of Lewin’s theory is
depicted in Figure 1.
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Figure 1. Lewin’s Force-Field Model of Change.
Driving
Forces
Present level of
equilibrium
(status quo)

Restraining
Forces

Unfreezing
requires a change
degree or number
of driving vs.
restraining forces

Addition of
Driving
Forces

Removal of
Restraining
Forces
Movement occurs
as driving forces
overcome
restraining forces

Refreezing in the
new state of
equilibrium occurs
until the change
process occurs
again.

New Driving
Forces

New
Restraining
Forces

Adapted from Effective Leadership & Management in Nursing, 6th ed by Eleanor Sullivan &
Phillip Decker and Field Theory in Social Science by Kurt Lewin.
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Change in a large organization, such as a hospital, is difficult to create
since restraining forces for change are many, varied, and sometimes not readily
apparent due to the complexity of their nature. Some restraining forces to change
in a hospital environment include healthcare personnel resistance to change,
limited access to learning opportunities or resources that may provoke change,
lack of institutional support for change and, lack of resources to initiate change.
Recent changes in driving forces at the hospital for this study include a renewed
and collective commitment by hospital leadership to improve stroke care. That
commitment is due in part to the newly developed JCAHO Primary Stroke Center
certification program. Acknowledgment and support by leadership of the need to
unfreeze the current state of equilibrium related to stroke care is essential to
removing or reducing restraining forces and adding or strengthening driving
forces. The hospital made a commitment to add driving forces such as a
physician champion for stroke care, a stroke nurse coordinator, and program
oversight by a designated director of nursing. Reduction in restraining forces was
planned to evolve as staff are provided opportunities and resources to integrate
new guidelines for stroke care into their practice.
As an initial step in the change process to reduce restraining forces, an
educational event in the form of a workshop was presented (Appendix F). The
target audience for this workshop was staff from inpatient, rehabilitation and
home health nursing as well as physical therapy, occupational therapy, speech
therapy, and emergency response personnel. This workshop introduced the
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recently published acute stroke guidelines and the planned implementation of the
stroke clinical pathway. Implementation of the stroke clinical pathway required
addition of driving forces and is intended to reduce restraining forces by making it
easier for practitioners to meet the new standards of care for stroke. Other efforts
to induce alterations in the forces included presentations of the clinical pathway
by the stroke physician champion to other physician groups involved in the care
of stroke patients. The hospital marketing department supplemented the
presentations by sending informational mailings to those same physician groups.
The implementation of a comprehensive clinical pathway for stroke is one
component of a hospital-supported stroke initiative and a tangible step in the
change process. If successful change occurs, as demonstrated by improved
documentation of disease-specific measures for stroke, and the hospital moves
to a new state of change, the next step is to refreeze in order to hold any gains in
improvement of stroke measures. Measurement of compliance with quality
indicator documentation is necessary to maintain positive changes and alter
forces to further improve stroke quality of care.
Justification for the Study
Evaluation of compliance with disease-specific measures for stroke will
enable the hospital to identify areas where practice guidelines and evidencebased practice can be better integrated into clinical practice by the
multidisciplinary team. Any effect of a clinical pathway in consideration and

13

documentation of those measures will influence future decisions about process
improvement opportunities.
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CHAPTER II
LITERATURE REVIEW
The purpose of this chapter is to provide a review of current literature
related to practice guidelines, JCAHO Disease-Specific Care certification for
stroke, and clinical pathways. A description of how the literature influenced the
creation of the stroke clinical pathway for this study follows.
Practice Guidelines
Evidence-based medicine emerged in the 1990’s to help clinicians make
treatment decisions based on current medical research. The use of evidencebased medicine is intended to improve patient care and outcomes by providing
the clinician with more information about a disease state than may be gained
through experience and formal training (Evidence-Based Medicine Working
Group, 1992). It is through review of current research that practice guidelines are
formulated and agreed upon by a consensus of clinical experts (Guyatt, Sinclair,
Cook, & Glasziou, 1999). Practice guidelines therefore represent a standard of
care for management of a particular disease state. The American Heart
Association (AHA) developed a working definition of disease management in
2004. The expert panel defined disease management as “multidisciplinary efforts
to improve the quality and cost-effectiveness of care for selected patients
suffering from chronic conditions” (Faxon, et al., 2004, p 1528). Disease
management programs should be based on scientifically derived and peer-
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reviewed guidelines from which specific performance measures are identified to
aid the evaluation of those programs (Faxon, et al., 2004).
A movement toward evidence-based practice in nursing has also arisen in
recent years. As nurse leaders evaluate standards for practice, more emphasis is
beginning to be placed on interventions that are based on research and quality
outcomes rather than tradition (Milton, 2007; Penz & Bassendowski, 2006;
Melnyk, et al., 2004; Deaton, 2001). The concept of evidence-based practice in
nursing may be considered the gold standard, and its adoption is evidenced by a
trend toward hospital policy and procedure manuals that are based on available
research. The integration of evidence-based guidelines into nursing practice can
be challenging since nurses who deliver care at the bedside may not be prepared
with the skills or the resources to do so (Springer, Corbett, & Davis, 2006).
Strategies for introducing clinical guidelines into nursing practice include general
dissemination of the information in nursing journals, targeting specific groups of
nurses whose practice may be affected by the guidelines, and providing
educational interventions to selected groups of nurses. To encourage
implementation of practice guidelines, strategies could include providing
reminders and making the guidelines readily accessible to the targeted nurses.
Inclusion of the guidelines in the form of prompts into existing systems of
required documentation would also be useful (Craig & Smyth, 2002).
The American Stroke Association (ASA) published a new set of guidelines
in 2003 for the management of acute ischemic stroke patients. These guidelines
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were intended to assist physicians in primary care, emergency medicine,
neurology, and other disciplines involved to make informed decisions about the
acute management of stroke victims (Adams, Adams, Brottt, et al., 2003).
JCAHO used guidelines and scientific statements for stroke management to
develop ten disease-specific measures for stroke. The ASA published an update
to its acute stroke management guidelines in 2007, with the intention of future
updates every three years (Adams, Del Zoppo, et al.). Many of the
recommendations are unchanged from the 2003 publication, but there were
some substantial additions. One such addition includes a strong recommendation
for the creation of primary stroke centers that are certified through an external
body such as JCAHO (Adams, Del Zoppo, et al., 2007).
The Centers for Medicare & Medicaid Services (CMS) initiated a Hospital
Quality Initiative (HQI) program to address the burden of select disease states on
America. The purpose of the program is to promote informed decision making by
consumers about healthcare choices, provide incentives to hospitals that improve
patient care, and support public accountability for that care (Centers for Medicare
& Medicaid Services, 2005). The measures chosen for comparison by CMS are
derived from current medical research and are factors likely to positively impact
patient outcomes. CMS has worked in collaboration and support with various
other entities interested in improving patient outcomes including JCAHO.
Although stroke is not presently a disease state measured by CMS through the
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HQI program, the same method of reporting HQI indicators for improving and
measuring quality of care should be applied.
The ASA recognizes there are significant obstacles to consistently
integrating scientific advances into clinical practice (Schwamm, Pancioli, et al.,
2005). Making sure that practice guidelines actually guide clinical practice
requires educating the clinician about the existence of and value to patient care
of such recommendations. Once the clinician is knowledgeable about standards
of care for the diagnosis and treatment of a specific disease process, it is
reasonable to infer that clinical practice will also be affected. A clinical pathway
for stroke could act as an educational tool to guide those clinicians unfamiliar
with current standards of care. If clinical practice were affected by the
incorporation of stroke guidelines, documentation in the medical record would
reflect the change. It is through the documentation of medical care and the
decision-making process that hospitals are able to demonstrate the quality of
care provided.
In 2004, the Canadian Stroke Quality of Care Study proposed a core set
of performance indicators for stroke that is similar in nature to the
recommendations from the ASA (Lindsay, Kapral, Holloway, et al., 2005;
Lindsay, Kapral, Gladstone, et al., 2005). In a separate publication, the core
performance indicators for stroke were compared to the best-practice guidelines
for nurses published jointly by the Heart and Stroke Foundation of Ontario and
the Registered Nurses’ Association of Ontario. A few examples of the role of
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nursing in meeting those measures include the safe and timely administration of
medications, monitoring and acting to prevent potential complications of medical
therapy, and educating the patient about risk factor modification. The comparison
demonstrated a role for nursing in the improvement of performance measures for
the acute stroke patient (Lindsay, Kelloway, & McConnell, 2005). Nurses in the
United States share the same role in meeting the disease-specific measures set
by the JCAHO for stroke center certification.
Documentation is an indirect measure of integration of guidelines into
patient care. The patient medical record should confirm if disease-specific quality
measures are met or identify patient-specific contraindications. Development of
quality measures and auditing for compliance with those measures enables a
hospital to identify the level of medical care provided and take action as
necessary to improve that care (Walter, Davidowitz, Heineken, & Covinsky,
2004).
JCAHO Primary Stroke Center Certification
JCAHO offers a Disease-Specific Certification Program for stroke to
hospitals seeking to improve quality, decrease disability, and control costs
related to stroke care while working toward designation as a JCAHO certified
Primary Stroke Center. A Primary Stroke Center must incorporate current
guidelines and recommendations from the ASA and other sources of authority on
stroke care into its framework. The certification guide addresses factors related
to the diagnosis and treatment of patients experiencing acute ischemic stroke,
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hemorrhagic stroke, and TIA. Hospitals are required to report performance
measures for these three diagnoses to obtain JCAHO Primary Stroke Center
certification (JCAHO, Performance Measurement Implementation Guide, 2004).
Based on review of the literature, JCAHO developed a set of ten
performance measures judged to influence patient outcomes (Table 1). A data
collection tool (Appendix G) for tracking the ten measures and other performance
indicators is also provided by JCAHO (JCAHO, Performance Measurement
Implementation Guide, 2004). While JCAHO has not yet made changes to the
Stroke Performance Measurement Implementation Guide based on the updated
ASA recommendations for 2007, it is expected that they will do so in the near
future.
In an effort to help hospitals assess compliance with disease-specific
performance measures, the AHA developed data management tools for coronary
artery disease, heart failure and stroke. Get with the Guidelines – Stroke
(GWTG-Stroke) is an instrument designed to aid in the collection of the ten
JCAHO disease-specific measures. It is also used to collect critical time
measures in the initial presentation and treatment of acute stroke. It uses the
same criteria for measurement provided by JCAHO, but uses reminders about
missing data, deviation from guidelines, and has patient education materials that
can be printed on demand. When GWTG-Stroke is used, either concurrently or
retrospectively, it can assist with identification of deviations from current
guidelines and assessment of variances to a stroke clinical pathway.
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Early studies using the GWTG-Stroke instrument suggested an
association in improvement of at least four of the JCAHO stroke measures
(antithrombotic administration, anticoagulation for atrial fibrillation, lipid
measurement, and smoking cessation counseling) when it was used to
concurrently collect data in the hospital setting (LaBresh, et al., 2005).
Compliance with measurements for the acute interventions of administration of
antithrombotics and intravenous thrombolytics also increased in hospitals using
GWTG-Stroke. By the end of the fourth quarter of use at 99 hospitals utilizing
GWTG-Stroke, evidence of physician consideration of thrombolytic therapy was
present for all but 15% of acute stroke patients (Schwamm, LaBresh, et al.,
2005).
Clinical Pathways
Although there is no single model of a clinical pathway, many are
comprised of a document for physician ordering and nurse charting. A clinical
pathway should set expectations for a typical course of care from admission to
discharge, require education for patients and families, decrease unnecessary
utilization of resources by discouraging unnecessary tests and procedures,
provide a system for monitoring patient outcomes, and eliminate duplication
(Guinane, 1997). Documents for a clinical pathway may include patient care
plans with discipline-specific responsibilities and interventions, while also
dictating the timing of services provided. Other documents may include researchbased protocols for reference, standardized physician order sets, documentation
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forms, and checklists (Lanska, 1998). A key element to a successful clinical
pathway is integration of the tool into the existing documentation processes
within a facility. Streamlining the documentation process reduces the perception
of additional work and increases use of a clinical pathway (Guinane, 1997).
In an effort to guide clinical practice so that it conforms more closely to
current medical evidence, controls healthcare cost, and improves patient
outcomes, hospitals have often utilized clinical pathways. Population-specific
clinical pathways became popular in the 1990s in response to the managed care
movement and were often based on a targeted length of stay (Lagoe, 1998).
During this era, Hydo (1995) outlined the process required to design an effective
stroke clinical pathway. This included physician orders with cues, a daily nursing
documentation form with a case management plan, and a corresponding patient
education tool. This pathway was used at a Michigan hospital where the true
benefit of the clinical pathway at the facility was that it identified areas of process
improvement and prompted positive changes for stroke care.
In order to evaluate the impact of implementation of a clinical pathway for
stroke, both hospital-specific and disease-specific variables should be identified.
Those criteria or measures identified must be integrated into each stage of a
pathway in order to produce change. A 1997 study involving the implementation
of stroke clinical pathways at several hospitals identified the need to individualize
pathways to capture information for specific variables. Each hospital in the study
chose clinical pathway variables that met its own quality improvement needs
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while also agreeing to collect a common set of variables such as length of stay,
use of resources, and clinical outcomes (Hainsworth, Lockwood-Cook, Pond, &
Lagoe). A British study explored the effects of an “integrated clinical pathway” in
a hospital’s acute stroke unit by comparing patient outcomes and care processes
in an intervention and control group. At the end of the study, quality of
documentation in the intervention group was significantly improved, a CT scan
was more likely to be done within 24 and 48 hours, and there was a lower rate of
urinary tract infection (Kwan, Hand, Dennis, & Sandercock, 2004).
Bonnono, Criddle, Lutsep, Steven, Kearns & Norton (2000) described the
use of an ‘emergi-path’ for stroke intended to act as a patient care guide and
documentation tool for members of the stroke team in the emergent phase of
stroke. It included outcome goals for the patient and defined what nurses and
physicians should document in the medical record related to stroke care. The
emergi-path included orders for the acute evaluation of patients with stroke
symptom onset of less than 24 hours, as well as instructions for the evaluation of
thrombolytic eligibility. The goal of the emergi-path was to increase the
percentage of acute ischemic stroke patients who received intravenous
thrombolytics within three hours of symptom onset. However, data was not
provided in the article to suggest if use of the emergi-path resulted in increased
use of t-PA for stroke at the facility.
An Australian hospital revised an existing, but underutilized, stroke clinical
pathway into a more patient-centered documentation form. The pathway included
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automatic referrals and consultations, which resulted in a decreased average
length of stay and improved clinical outcomes due to the required involvement of
specialists (Wilkinson, Parcell, & MacDonald, 2000). The California Acute Stroke
Pilot Registry (2005) reviewed use of standardized order sets for stroke in a
number of hospitals. For hospitals using standardized stroke orders, an
improvement in documentation of deep vein thrombosis (DVT) prophylaxis, lipidlowering medications at discharge, and antithrombotics at 48 hours and
discharge was demonstrated.
Kwan and Sandercock (2004) conducted a review of in-hospital care
pathways for stroke for Cochrane Database and concluded there was insufficient
evidence to support the use of stroke clinical pathways in the acute care and
rehabilitation settings. The review included three randomized trials and 12 nonrandomized studies and determined there was not a significant difference
between control groups and pathway groups in comparison of mortality rates or
discharge destination. It appeared that patients managed with a stroke clinical
pathway were more dependent at discharge, but less likely to be readmitted.
They were also less likely to have a urinary tract infection, and more likely to
have neuroimaging studies. Counter intuitively, the review also suggested
evidence of a lower rate of patient satisfaction and a lower quality of life with
clinical-pathway managed stroke patients. This suggests that a stroke clinical
pathway may not be a panacea for optimal patient outcomes.
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Examples of physician order sets and clinical pathways for stroke
management are readily available through a simple internet search. The ASA
and the Brain Attack Coalition have copies of physician orders and clinical
pathways for stroke available on their websites from hospitals active in improving
stroke care. Availability of such forms suggests that use of standard order sets
and clinical pathways are routinely used in the care of stroke patients across the
United States. In fact, the ASA specifically recognizes the need for stroke clinical
pathways and stated such tools should be used consistently in an organization to
minimize stroke progression and complications (Swhamm, Pancioli, et al., 2005).
The National Stroke Association hosts a Stroke Center Network electronic
mailing list where a frequent topic of discussion for stroke care professionals
seeking information to improve processes at hospitals where they work, is the
utilization of order sets and pathways that include stroke protocols (National
Stroke Association, n.d.). Discussions are archived for retrieval by Stroke Center
Network members.
The implementation of a comprehensive stroke clinical pathway may
improve the use of clinical guidelines for the management of stroke patients. For
a clinical pathway to do this, it must be designed to fit the needs of a specific
organization and blend with current documentation practices. One of the major
obstacles to success of a clinical pathway is lack of use by the multidisciplinary
team involved in patient care. A restraining force is a lack of investment and
support by the stroke management team for use of a clinical pathway. To limit
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barriers to pathway implementation, restraining forces should be minimized and
driving forces emphasized. It is therefore imperative that a clinical pathway not
require significant alteration in existing processes for writing orders and
documenting care at the hospital where it is implemented.
Stroke Clinical Pathway Development and Implementation
In 1998, at the hospital for this study, a CareMap® for stroke was
designed and implemented that was based on an eight day length of stay
requiring multidisciplinary documentation. A standardized stroke order set was
implemented in conjunction with the CareMap®. However, use of the pathway
by physicians, nurses and therapists was limited and the CareMap® was
eventually abandoned. The physician orders developed for the CareMap® were
converted into generic stroke admission orders and continue to be used by the
neurologists.
In 2006, at the study hospital, a team led by the Director of Nursing for the
neuroscience unit and the affiliated rehabilitation hospital began implementation
of a new stroke initiative. This multidisciplinary team was comprised of
physicians, nurses, therapists, and other disciplines from the emergency,
neuroscience, radiology, rehabilitation, pharmacy, and nutrition departments. A
long-term goal for the team was to prepare the hospital for JCAHO Primary
Stroke Center certification by improving, revising, and refining existing processes
for the management of stroke patients. Using a collaborative effort, this team
identified ongoing areas of improvement in the process of stroke care. A
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comprehensive stroke clinical pathway was one of the needs identified and
development of the pathway was delegated to the Neuroscience Clinical Nurse
Educator.
The stroke clinical pathway was developed to consist of three physician
order sets for the different phases of hospitalization, an interdisciplinary plan of
care, and an education/flow sheet which lists topics for patient/family education
by members of the patient care team. Development of a comprehensive stroke
clinical pathway required the input and review of all disciplines involved in care
of a stroke patient.
Currently, a Stroke Care Team consisting of case management, nursing,
physical therapy, occupational therapy, speech therapy, and nutrition meets
twice weekly for multidisciplinary rounds on the neuroscience unit where the plan
of care for each stroke patient on the unit is discussed. The same therapists see
stroke patients throughout the hospital and are experts within the facility. This
multidisciplinary group of professionals participated in the creation of all the
documents developed for the stroke clinical pathway and provided valuable input
based on specialty.
One neurologist, acting as a physician champion for stroke care, was
closely involved in the development of the physician order sets, multidisciplinary
documentation forms and patient education handbook. The physician order sets,
plan of care, and education flow sheet were presented as a “stroke clinical
pathway” and approved by the Neuroscience Section. The Neuroscience Section
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membership consists of all neurologists and neurosurgeons with privileges at the
study hospital and is committed to addressing clinical issues related to care of
the neuroscience patient.
The stroke clinical pathway was designed to improve compliance with the
ten JCAHO disease-specific measures (Table 2). In addition, the clinical pathway
forms were developed to meet hospital-defined criteria for documentation as
follows:
1.

Appropriate for ischemic stroke, hemorrhagic stroke, and TIA

2.

Address stroke patient management in the emergency department, at
inpatient admission, and upon discharge

3.

Incorporate an interdisciplinary plan of care with interventions and
outcomes specific to stroke, an anticipated length of stay, and a
patient version of the care plan

4.

Include a patient/family education form with identified stroke
education topics

The individual forms of the stroke clinical pathway were approved by all
hospital-required committees and implemented in April 2006. Each of the
physician order sets and multidisciplinary forms are available online via the
hospital intranet and computerized order entry/documentation system. All
registered nurses on the neuroscience/stroke unit have been educated about the
stroke clinical pathway and trained in the assessment of stroke patients and are
certified by the ASA in the use of the National Institute of Health Stroke Scale
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(the standard assessment tool identified in the stroke clinical pathway). Additional
education for nurses and therapists was identified and provided at the
department level as needed.
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CHAPTER III
METHODS AND PROCEDURES
Study Design
The ten JCAHO disease-specific criteria identified by JCAHO for stroke
were the variables of measurement for this study. Compliance rates of
documentation in the medical record were compared for each of the ten JCAHO
disease-specific measures before and after stroke clinical pathway
implementation. Two retrospective chart reviews were conducted to determine
documentation compliance rates. The first review included 110 stroke patient
records (baseline data) discharged in the year prior to clinical pathway
implementation. The second review included 110 stroke patient records six
months after the implementation date. The compliance rates for each of the ten
measures were compared from the baseline data to the post-clinical pathway
implementation data. Comparison of the compliance rates for each measure was
used to determine if there was statistically significant improvement in the level of
documentation in the medical record. Comparison of the documentation rates for
patients with the stroke clinical pathway and those without was also completed.
Fisher’s Exact test was used to assess differences between the baseline and
post-intervention rates. Confidence intervals of 95% were calculated for the
baseline and post-intervention compliance rates.
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Sample
JCAHO defined requirements for sample population and size in its
implementation guide for stroke center certification. As instructed by the JCAHO
Performance Measurement Implementation Guide’s (2004) section on sampling
(Appendix H), 20% of adult stroke admissions were sampled to provide a
baseline data set. A query of patients over the age of 18 with stroke ICD-9-CM
codes identified by JCAHO was performed (Table 3). This query identified 550
adult stroke patients discharged between the dates of January 1, 2005 and
December 31, 2005. The hospital’s quality management department chose a
weighted random sample of 110 charts based on the three categories of stroke.
There were 334, 114, and 102 total patients in the ischemic stroke, hemorrhagic
stroke, and TIA population groups, respectively (Table 5). Twenty percent
samples were taken within each group using random numbers generated through
an online randomization software program (Research Randomizer, n.d.)
Table 5. Sampling Numbers for Control Group
Total # in Population

# in 20% Random
Sample

Hemorrhagic

334
114

67
23

TIA

102

20

Ischemic

Instruments and Data Collection
The GWTG-Stroke database, which covers the JCAHO measures, was
used for data collection. Appendix G includes the JCAHO data collection tool
from which the GWTG-Stroke Patient Management Tool (PMT) was designed.
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Data entry training of authorized persons by Outcome Sciences, Inc., the
administrators of the AHA GWTG-Stroke database, was provided once the tool
was purchased by the study hospital. The primary data collector was the
Neuroscience Clinical Nurse Educator. Six other data collectors included nurses
from the Neuroscience Center and a Clinical Nurse Specialist working within the
same department. The compliance rates for measure documentation were
reported as aggregate data.
Data Management
Patient records were de-identified at the point of data entry into the
GWTG-Stroke database for confidentiality purposes. The GWTG-Stroke
database requires a user password and requires assignment of a unique number
to each patient record. Numbers were assigned 1-110 for the baseline group and
1001-1110 for the intervention group. A separate cross-reference file with both
numbers was maintained. The hospital’s quality management department may
use any demographic information collected within this database. These data
include age, gender, race, admitting and consulting physician services,
admission location within the hospital, and utilization of the stroke clinical
pathway. This information could also be analyzed for trends in the diseasespecific measures related to any of these demographics. The GWTG-Stroke
database includes basic reports and the hospital’s quality management
department assisted in analyzing all data results included in this study.
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The GWTG-Stroke PMT was used to collect the data for the 220 patients
in the control and intervention group through medical record review. Data was
entered from the PMT into the GWTG-Stroke database. Optional fields within the
database were designated to note the use of each component of the stroke
clinical pathway for the intervention group.
Limitations
The sampling methods for this study were based on the JCAHO
Performance Measurement Implementation Guide 2004) to best represent the
stroke population at the study hospital. Within the intervention group, comparison
of measure compliance for patients with the clinical pathway present versus
those without resulted in a smaller sample size within the 110 patient record
intervention group. Another threat to the validity of the study is in the data
collection method which utilized six different data abstractors (i.e. inter-rater
reliability). Although the GTWG-Stroke database has coding instructions for the
data collector, there remains some ambiguity about how specific the
documentation must be to meet the performance measure criteria. Efforts to
reduce inter-rater variability included consultation with a clinical operations
analyst in the quality management department to clarify the type of
documentation required to meet the coding requirements. The more ambiguous
measures were also reviewed by the lead researcher as each record was
entered into the GWTG-Stroke database.
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CHAPTER IV
RESULTS
This chapter presents the results of the statistical analysis for the control
group versus the intervention group and within the intervention group, the no
clinical pathway group versus the clinical pathway group. Additional evaluation
of the use of the stroke clinical pathway in relation to specific performance
measures follows.
Control Group versus Intervention Group
The GWTG-Stroke database is designed to run configured reports for the
ten JCAHO performance measures. The “JCAHO Pilot-10” report extracts the
numerator and denominator for each measure as defined by the JCAHO Stroke
Performance Measurement Implementation Guide from all patient records
entered into the database. A JCAHO Pilot-10 report was run for the control group
and the intervention group. The report provided a spreadsheet detail for each
quality measure. The spreadsheet indicated which patient records were included
and excluded from the measure criteria and if the measure was met or not met.
The patient records included for each measure in the intervention group were
then matched with the corresponding optional field data that indicated which
element of the stroke clinical pathway was used in the patient record. From this
information, a final spreadsheet was created to identify, for each patient record, if
the individual quality measure was met, not met, or excluded. An additional
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indicator was used for the intervention group to identify use of the stroke clinical
pathway.
The data were then analyzed using SAS v9.0 software (Statistical Analysis
System, Cary, NC). Compliance rates were compared using Fisher’s Exact test
and 95% confidence intervals. P-values <0.05 were considered indicative of
statistical significance. This analysis compared the control and the intervention
group for compliance with each measure. The same analysis was completed
within the intervention group to compare the compliance rate for each measure
for those patients with at least one form of the stroke clinical pathway utilized.
Results of documentation compliance for the control group versus
intervention group are detailed in Table 6 and shown as a graph in Figure 2.
Statistically significant differences are noted with an asterisk.
There were no statistically significant differences between the compliance
rates for documentation of the following measures:
•

DVT prophylaxis

•

antithrombotic at discharge

•

anticoagulant for atrial fibrillation

•

consideration and administration of t-PA

•

antithrombotic within 48 hours

•

presence of lipid profile

•

dysphagia screening

•

planning for rehabilitation
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While six patients were potentially eligible, no patients received t-PA in the
intervention group. The GWTG-Stroke database allows the data collector to infer
the presence of contraindications to t-PA regardless of specific documentation by
the physician. Six patients arrived at the study facility’s emergency department
within 180 minutes of stroke symptom onset as documented in the medical
record. However, there was insufficient documentation to allow the data
collectors to infer the precise contraindications apparent to the physician, which
prohibited t-PA administration. Further analysis of the records for patients
potentially eligible for thrombolytics would be useful to identify opportunities for
process improvement.
The control group versus the intervention group demonstrated statistically
significant improvements in the documentation compliance rates for
patient/family stroke education (p<0.001) and smoking cessation counseling
(p<0.001). However, the large improvement in the smoking cessation measure
cannot be attributed to the implementation of the stroke clinical pathway. In 2006,
the hospital implemented changes in the nursing admission history to meet CMS
standards for documentation of smoking cessation counseling by prompting the
nurse to document materials provided to the patient. Those changes were
sufficient to meet the documentation requirements for the stroke measure. A
computerized charting system used in the Emergency Department also included
a notation for smoking cessation counseling and was present in the medical
records for smokers in both the control and intervention groups. However, the
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simple notation that smoking cessation counseling was provided did not meet
measure criteria based on the GWTG-Stroke database coding instructions
(Stroke Coding Instructions v7.2, 2006).
Improvement in documentation of stroke education may be equally
attributed to the use of the clinical pathway forms as to the process of pathway
implementation. There was an increase in documentation of stroke education in
the intervention group even in the absence of the clinical pathway. Nursing, as a
discipline, most consistently documented patient/family stroke education in the
medical record. The increased documentation rate in patients without the clinical
pathway may be attributed to the raised awareness about stroke education and
resource availability among nurses who had used the pathway with other
patients, or attended workshops where the clinical pathway was presented.
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Table 6. Measure Compliance for Control Group vs. Intervention Group
Number
Fisher’s
DSC Stroke
(%)
Exact Test
Group
N
Measure
compliant
p-value
1

Deep vein thrombosis
prophylaxis

Control
Intervention

39
37

36
33

(92.3)
(89.2)

0.71

2

Discharged on
antithrombotics

Control
Intervention

80
72

76
72

(95.0)
(100)

0.12

Control
Intervention

7
12

7
11

(100)
(91.7)

1.00

Control
Intervention

12
15

7
10

(58.3)
(66.7)

0.71

Control
Intervention

5
6

3
0

(60.0)
(0.0)

0.06

Control
Intervention

72
71

70
67

(97.2)
(94.4)

0.44

Patients with atrial
3
fibrillation receiving
anticoagulation therapy
Tissue plasminogen
4A
activator (t-PA) considered
Tissue plasminogen
4B activator (t-PA)
administered
Antithrombotic medication
5
within 48 hours of
hospitalization
6

Lipid profile

Control
Intervention

85
76

49
55

(57.6)
(72.4)

0.07

7

Screen for dysphagia

Control
Intervention

84
68

31
27

(36.9)
(39.7)

0.74

8

Stroke education

Control
Intervention

10
8
90

6
24

(5.6)
(26.7)

<0.001*

9

Smoking cessation

Control
Intervention

26
21

8
19

(30.8)
(90.5)

<0.001*

10

A plan for rehabilitation
was considered

Control
Intervention

88
70

75
64

(85.2)
(91.4)

0.33

* Significant at the 0.05 level
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Figure 2. Comparison of Control Group Measures to Intervention Group

○Control

Items marked with an

*

□ Intervention

indicate statistical significance
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Intervention Group versus Clinical Pathway Group
Analyses within the intervention group to determine the influence of stroke
clinical pathway use on documentation of the ten JCAHO disease-specific
measures were completed. Thirty-three (30%) of the 110 patients in the
intervention group had at least one form of the stroke clinical pathway utilized.
Data analyses within the intervention group comparing documentation
compliance for patients with the stroke clinical pathway/order sets in use and
those without are summarized in Table 7 and as a graph Figure 3. Measures with
statistically significant improvement are noted with an asterisk. There were no
statistically significant differences in the compliance rates in the following stroke
performance measures:
•

DVT prophylaxis

•

antithrombotic at discharge

•

anticoagulant for atrial fibrillation

•

consideration and administration of t-PA

•

antithrombotic within 48 hours

•

dysphagia screening

•

smoking cessation counseling

•

planning for rehabilitation
There was a noticeable difference in the t-PA considered performance

measure for the clinical pathway group (88.9%) versus the no clinical pathway
group (33.3%), but it was not statistically significant. It is, however, clinically
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significant that documentation of consideration for t-PA, the only Food and Drug
Administration (FDA) approved medication to treat acute stroke, was present in
the medical record. It is interesting to note that for some patient records, the only
physician documentation of t-PA consideration was on the Stroke Admission
Orders.
One patient record out of five with atrial fibrillation in the clinical pathway
group did not have documented contraindications to anticoagulation. The Stroke
Admission order set used for this patient has a medication section containing the
statement “Anticoagulant for ischemic stroke of cardioembolic source”, but does
not prompt documentation of contraindications to anticoagulant therapy. The
Stroke Interdisciplinary Plan of Care has prompts for nursing related to this
measure, but was not used for this patient.
The smoking cessation measure was not met for two patients in the
clinical pathway group. One patient had only the Emergency Department Orders
of the clinical pathway in place, which does not address smoking cessation. The
other patient had all elements of the clinical pathway used except the Stroke
Admission Orders, most of which include smoking cessation-counseling prompts.
For this patient, the clinical pathway did not ensure adequate documentation of
smoking cessation counseling or treatment. The documentation prompts
embedded in the nursing admission history previously referenced were not
utilized for either of these two patients.
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Two of the stroke performance measures in the intervention group had a
statistically significant improvement when the stroke clinical pathway was utilized.
Those measures were patient/family stroke education and lipid profile.
Over half of the patients with the clinical pathway had patient/family stroke
education documented. The Stroke Admission Orders include an order for
patient/family stroke education and was present on 80% of the charts with
required documentation. Over 50% of the charts with stroke education
documentation had the Stroke Interdisciplinary Plan of Care and the Stroke
Interdisciplinary Patient/Education Flow Sheet present in the record. The
increased rate of compliance with stroke education may be attributed to the
clinical pathway. Although location of the patient in the hospital was not a
variable for this study, it is noteworthy that all patients with documentation of
education on the clinical pathway were admitted or transferred to the
neuroscience/stroke unit.
Two patient records with the clinical pathway utilized did not have lipid
profile results available. A lipid profile is a pre-checked item on the Stroke
Admission Orders; therefore, any patient admitted with the order set should have
had a lipid profile drawn. The Stroke Admission Orders were used for one of the
patient records, but no results were available.
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Table 7. Measure Compliance for No Clinical Pathway Group vs. Clinical
Pathway Group
Fisher’s
DSC Stroke
Number (%)
Exact Test
Group
N
compliant
Measure
p-value
Deep vein
No Pathway
24
21
(87.5)
1
thrombosis
1.00
Pathway
13
12
(92.3)
prophylaxis
2

Discharged on
antithrombotics

Patients with atrial
fibrillation receiving
3
anticoagulation
therapy
Tissue plasminogen
4A activator (t-PA)
considered
Tissue plasminogen
4B activator (t-PA)
administered
Antithrombotic
medication within 48
5
hours of
hospitalization

No Pathway
Pathway

45
27

45
27

(100)
(100)

-

No Pathway
Pathway

7
5

7
4

(100)
(80)

0.42

No Pathway
Pathway

6
9

2
8

(33.3)
(88.9)

0.09

No Pathway
Pathway

4
2

0
0

(0.0)
(0.0)

-

No Pathway
Pathway

43
28

39
28

(90.7)
(100)

0.15

6

Lipid profile

No Pathway
Pathway

48
28

29
26

(60.4)
(92.9)

0.003*

7

Screen for
dysphagia

No Pathway
Pathway

47
21

16
11

(34.0)
(52.4)

0.19

8

Stroke education

61
29

9
15

(14.8)
(51.7)

<0.001*

9

Smoking cessation

11
10

11
8

(100)
(80)

0.21

10

A plan for
rehabilitation was
considered

47
23

41
23

(87.2)
(100)

0.17

N No
Pathway
Pathway
No Pathway
Pathway
No Pathway
Pathway

* Significant at the 0.05 level

43

Figure 3. Comparison of No Clinical Pathway Group Measures to Clinical
Pathway Group

○No Pathway

Items marked with an

*

□ Pathway

indicate statistical significance
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Additional Findings
The form most often used from the stroke clinical pathway was the Stroke
Admission Orders. This form includes a section directing the admitting nurse to
initiate the Stroke Interdisciplinary Plan of Care and utilize the Stroke
Interdisciplinary Patient/Family Education Flow Sheet and Handbook. These
forms were the second and third most utilized elements of the clinical pathway
respectively (Table 8). Of the 33 patients with the clinical pathway, 17 had at
least one element in the pathway present. Only one chart had all stroke clinical
pathway forms utilized (Table 9).

Table 8.

Number (%) of Each Clinical Pathway Form Present
Interdisciplinary
Patient/Family
Emergency Admission Discharge Interdisciplinary
Education Flow
Orders
Orders
Orders
Plan of Care
Sheet &
Handbook
7
(21.2%)

26
(78.8%)

4
(12.1%)

12
(36.4%)

11
(33.3%)

Table 9. Number (%) with Multiple Clinical Pathway Forms Present
1 Form
2 Forms
3 Forms
4 Forms
5 Forms
17
(51.5%)

7
(21.2%)

6
(18.2%)

2
(6.1%)

1
(3.0%)

An analysis of the number of measures met in the control group,
intervention group, and clinical pathway group was completed to determine if
there was an increase in the documentation of multiple performance measures
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for each patient rather than the individual measure only. A Chi-square test for
linear trend revealed that the increased compliance with multiple measures for
patients on the clinical pathway was statistically significant (Table 10 & Figure 4).
The control group and intervention group, as a whole did not show the same
trend with multiple measures as the clinical pathway group.
Table 10. Number (%) of Records with Multiple Measures Met with and
without Clinical Pathway Forms Present
Number of
measures met

Number of
records

Number records (%) Number records (%)
without Pathway
With Pathway

0

15

14 (93.3%)

1 (6.7%)

1-2

21

19 (90.5%)

2 (9.5%)

3-4

36

27 (75%)

9 (25.0%)

5-6

26

13 (50.0%)

13 (50.0%)

7-8

12

4 (33.3%)

8 (66.7%)

% of Records with
Pathway Used

Figure 4. Graph of Increased Compliance of Measures Met with Clinical
Pathway Forms Used

80%

66.7%

60%

50.0%

40%
20%

25.0%
6.7%

9.5%

0

1-2

0%

3-4

5-6

7-8

No. of Measures Met
Note: p<0.001 from Chi-square test for linear trend. This indicates a statistically
significant increase in the # of measures met as the usage
of clinical pathway increases.
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A factor, which could have affected the study results, was the institution of
a multidisciplinary Stroke Discharge Team at the hospital. Starting in January
2007, this team met daily to facilitate discharge plans and notify physicians when
the stroke clinical pathway was not utilized. The data collected for this study
included 23 patients admitted after the multidisciplinary stroke team was formed.
The 23 patients did not show the same trend with documentation of multiple
measures as did the clinical pathway group. Ideally, however, a clinical pathway
is a tool used by a multidisciplinary team to promote the use of evidence-based
medicine and documentation of key quality indicators.
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CHAPTER V
DISCUSSION
The intervention group demonstrated statistically significant improvement
in the documentation of patient/family stroke education (p<0.001). This positive
change was also statistically significant in the intervention group when the stroke
clinical pathway was used (p<0.001). Patient/family education about the type of
stroke, treatment plan, and risk factor modifications are vital elements of quality
nursing care. Without education about modifiable risk factors, secondary stroke
prevention is limited. Thus, nurses play a pivotal role in helping the patient avoid
a second stroke. The Stroke Admission Orders direct the admitting nurse to
initiate and document stroke education. The improvement in this measure with
the use of a clinical pathway demonstrates how nurses effectively utilize a
physician order set as a checklist.
The pre-checked item for a lipid profile in the admission order set also had
a statistically significant influence on measure compliance (p<0.003). The
improvement demonstrates that it is useful to force compliance with some orders
rather than leaving it to the individual physician to make a choice. However, there
should be thoughtful consideration of which measures to enforce in this manner
to ensure individualization of patient care.
The clinical pathway not only led to improvement in two individual
measures, it improved the overall compliance with documentation of multiple
measures. Meeting more performance measures per individual patient is more
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indicative of quality patient care than improving compliance in only one measure.
This study suggests that implementation of a clinical pathway can help
physicians and nurses improve quality measure documentation.
Deficiencies in the clinical pathway process may have limited the clinical
pathway utilization. This may be the reason only 30% of patients in the
intervention group had any element of the clinical pathway in place. To make the
clinical pathway more user friendly, it should be simplified into as few documents
as possible, while not requiring additional effort to initiate. The Emergency
Department order sets were the second least utilized element of the pathway in
this study. The Emergency Department at the study facility uses a computerized
documentation and order entry system. Integrating performance measures into
that system would facilitate compliance with measures affecting patients entering
through that department. Customization of any computerized documentation
system can be a time consuming and costly endeavor, which may prove limiting.
The Stroke Discharge Orders were the least utilized component of the
clinical pathway. While the computer system at the facility was set up to
automatically print the Discharge Orders, it would only do so if the unit secretary
selected the “Stroke Admission” packet when the inpatient chart is prepared. If
the standard admission packet is selected, a generic discharge order form is
printed and placed on the chart that does not prompt the physician to consider
discharge quality measures. Computerized physician order entry (CPOE) could
help ensure discharge stroke measures are met by integrating prompts for
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patients with a stroke diagnosis. Currently, the study facility is in the initial stages
of transition to a CPOE system. The hospital’s discharge instructions for nursing
are already computerized, so inclusion of prompts for patients with stroke
diagnosis could enhance documentation of stroke performance measures at
discharge. Since some of the stroke measures at discharge are physician
initiated, the effectiveness of including prompts in the nursing discharge would be
limited.
While instructions to screen stroke patients for dysphagia were included in
the Stroke Admission Orders and the Stroke Interdisciplinary Plan of Care, there
are not specific prompts to ensure documentation of swallow screen by nursing
in the medical record. Inclusion of such instructions in future revisions of the
clinical pathway should be considered. Addition of a formal dysphagia screening
form that is completed by the bedside nurse prior to oral intake may be a useful
tool to include in the pathway. Such a tool should provide instructions to withhold
all oral intake for stroke patients with symptoms suspicious for impaired
swallowing until evaluation by a Speech Pathologist is completed.
The study facility currently utilizes a computerized nursing documentation
system, but it does not include the Interdisciplinary Plan of Care. Use of the
hospital’s generic Interdisciplinary Plan of Care form is not consistent. Use of the
Stroke Interdisciplinary Plan of Care was also limited as evidenced by this study.
Transition to a computerized plan of care could trigger documentation prompts
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for quality measures based on nurses’ charting. The hospital is investigating this
type of option.
Compliance with the measure of anticoagulant therapy for patients with
atrial fibrillation was high, but one patient with the clinical pathway did not meet
the measure criteria. Opportunity to document contraindications to anticoagulant
therapy in the clinical pathway may have helped with meeting this measure by
excluding the patient record from the denominator population. The measure for
consideration of t-PA could also have improved documentation with incorporation
of a prompt to document contraindications to thrombolytic therapy. These
additions should be considered with future stroke clinical pathway revisions.
Conclusions
A clinical pathway is always a challenge to implement and maintain due to
the complex nature of patient care. Success depends in part on the level of
pathway integration into existing documentation processes. Clinical pathways
have been used in various settings and in multiple formats to improve
documentation and streamline patient care with reports of mixed success (Kwan,
Sandercock, 2004).
The most recently published update to the ASA guidelines for acute
ischemic stroke management includes a recommendation for use of standardized
stroke care order sets to improve the general management of stroke patients
(Adams, Del Zoppo, et al., 2007). This is a new recommendation based on the
consensus that a clinical pathway is useful despite limited evidence from large
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trials. This study demonstrates that documentation, which is a reflection of care
given, can be improved by the incorporation of evidence-based guidelines into a
clinical pathway consisting of order sets, interdisciplinary care plans, and flow
sheets. However, the small number of patients in the intervention/clinical
pathway group of 33 patients limits the power to detect statistically significant
differences. Continued surveillance of the effect of the clinical pathway on
documentation in the study facility with the GWTG-Stroke tool is suggested to
further explore the relationship between the clinical pathway use and measure
compliance. Additional research into the subject is recommended on a larger
scale and in other institutions.
Development and implementation of a clinical pathway for stroke care
must be a multidisciplinary endeavor. While each discipline involved in the care
of the stroke patient at the study facility was consulted for input into pathway
development, it was on an individual basis rather than in a group forum. There
was not sufficient opportunity for the stroke care team to discuss existing
processes and how the clinical pathway could be utilized at each step in the
stroke patient’s hospital course. This lack of a comprehensive and ongoing team
commitment to the development and implementation of the clinical pathway very
likely reduced its acceptance and utilization.
Consistent and continuous feedback to physicians and nurses about use
of the clinical pathway and compliance with quality measures is vital to the
success of a clinical pathway in influencing care. A designated position such as a
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nurse coordinator to provide concurrent feedback about the clinical pathway to
the healthcare team would likely have had a positive effect on its use and
documentation. A multidisciplinary team active in the care of individual stroke
patients and in program development is necessary to improve compliance with
quality measures. A database such as GWTG-Stroke to gather data concurrently,
identify key measures specific to the stroke patient, and provide feedback on
compliance is a valuable tool for improving stroke care in a hospital.
Nursing Implications
This study has demonstrated that a stroke clinical pathway can have a
positive effect on documentation of specific quality measures and can increase
compliance with multiple measures for the individual patient. While the increase
in smoking cessation counseling cannot be attributed to the stroke clinical
pathway, it was a direct result of changes in the nursing documentation system,
similar to intent of the clinical pathway. Improvement in patient/family stroke
education, however, can be attributed the stroke clinical pathway. Nursing is
primarily responsible for patient/family education; providing learning resources,
reminders, and a checklist within the clinical pathway process proved to be
useful. However, even with the improvement in stroke education, only about onefourth of the patients in the intervention group had documented evidence that
stroke teaching occurred demonstrating there is still much work to be done to
meet this measure. Providing to each nursing unit involved in care of the stroke
patient, a compliance chart on a monthly basis may be a way to raise staff
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awareness of the value of this nursing intervention. The improvement in lipid
profile measure shows that it is effective to make some quality measures
mandatory, rather than leaving them to the discretion of the physician. This
principle would apply to nursing care orders as well.
The t-PA administration rates in the intervention group are of particular
concern and should received special attention. The control group had an overall
rate of t-PA administration of 4.5%, while the intervention group did not have any
patients. Individual chart analysis of those who arrived to the hospital’s
emergency department within three hours of symptom onset, may help in
identifying specific areas of process improvement for acute stroke evaluation.
Early identification and work-up of patients eligible for t-PA is vital. The earlier tPA is administered, the greater the possibility decreased disability and improved
outcome. Another measure for closer attention is the dysphagia. Staff education
focused on the importance of a swallowing evaluation for stroke patients will be
necessary. Incorporation of a dysphagia screening checklist for the nurse into
existing documentation systems should also be considered.
Unfortunately only 30% of the intervention group records had the stroke
clinical pathway in place. The lack of pathway acceptance by physicians and
nurses seriously undermines the potential benefits in quality measure
improvement. In retrospect, efforts to involve physicians and nurses in the
emergency department, intensive care unit, and the acute care unit to a much
greater degree in the development of the pathway could have resulted in a more
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successful pathway implementation. Staff in each of these departments should
be actively involved in all pathway revisions and may benefit from participating in
chart reviews to better identify deficiencies in documentation of quality measures.
Future research with this data should include further be analysis to identify trends
in measure compliance based on admitting physicians, consulting physicians,
and nursing unit as well as demographics such as age, ethnicity, and payor
source.
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Appendix E
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Appendix F
South Carolina Nurses Association Educational Content Objective Form
EDUCATIONAL ACTIVITY

OBJECTIVES

CONTENT (Topics)

TIME
FRAME
State the
time frame
for each
objective

List learner’s objectives
in behavioral terms

Provide an outline of the content
for each objective. It must be
more than a restatement of the
objective.

Introduction/Welcome

• Pretest
• Introduction of Case Study #1

10
minutes

• JCAHO Stroke Center
designation & stroke unit

4:004:10pm
15
minutes
4:10 –
4:25 pm

A. Recognize the value
of JCAHO Stroke
Center designation and
clinical pathway in
ensuring practice of
evidence based stroke
care.
B. Relate symptoms of
stroke type
and location of injury.

C. Discuss the scope of
emergency
department
management for
stroke patients.

Overview of stroke
• Population affected, statistics,
risk factors
• Types of stroke & causes
(ischemic, hemorrhagic, SAH)
• Arterial distribution &
correlating stroke symptoms
in ischemic stroke
• Type of stroke related to case
study
ED Management of acute stroke
• EMS
• Triage on arrival to ED
• Symptoms suspicious of
stroke
• Assessment
• Initial diagnostic tests
• BP management
• tPA assessment
• Case study presentation to
the ED
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30
minutes
4:25pm4:55pm

30
minutes
4:55pm5:25pm

PRESE
NTER
List the
Faculty
for each
objective
.
Katie
Woodfin,
BSN,
RN

METHODS
Describe the teaching
methods, strategies,
materials & resources
for each objective
Pretest form
Introduction of Case
Study of typical
stroke patient

Cynthia
Bishop,
MSN,
RN,
CRRN

Didactic

Lorette
Mitchem
, MSN,
ANP

Didactic
Lead group
discussion to relate
Case Study #1
patient symptoms to
possible type/location
of stroke
Question/Answer
opportunity

Martin
Lutz,
MD

Didactic (to include
Case Study #1
patient’s ED
experience)
Group discussion
Question/Answer
opportunity

OBJECTIVES

CONTENT (Topics)

List learner’s objectives
in behavioral terms

Provide an outline of the content
for each objective. It must be
more than a restatement of the
objective.

D. Describe the value of
radiology
testing for stroke.

Imaging for stroke
• Stat CT: rationale, normal
findings, abnormal findings.
• MRI: when, normal vs
abnormal
• CTA
• Angio
• Other radiology test
• Examples of stroke related
changes seen on radiology
films
• Radiology tests applicable to
case study and possible
results

Break

E. Explain the tests,
medications,
interventions, and risk
factor
modification for acute
stroke
treatment, prevention
of potential
complications and
second stroke.

Acute stroke treatment:
• TPA administration
• Rationales and implications
for diagnostic tests: MRI,
EKG, Echo, Telemetry,
Lipids, PT/PTT
• BP Management
• Antithrombotics
• Potential complications:
Oxygenation, fever, glucose
control, DVT prophylaxis
• Risk factor modification
• Neurologist admission orders

77

TIME
FRAME
State the
time frame
for each
objective
30
minutes

PRESE
NTER
List the
Faculty
for each
objective
.
Naveen
Parti,
MD

METHODS
List learner’s
objectives in
behavioral terms
D. Describe the value
of radiology
testing for stroke.

5:25pm5:55pm

20
minutes
5:55 6:15pm
45
minutes
6:15 –
7:00 pm

Break

John
Absher,
MD

E. Explain the tests,
medications,
interventions, and
risk factor
modification for
acute stroke
treatment,
prevention of
potential
complications and
second stroke.

OBJECTIVES
List learner’s objectives in
behavioral terms
F. Discuss the role of the
interdisciplinary team in
treatment of acute stroke
and case study

CONTENT (Topics)
Provide an outline of the content
for each objective. It must be
more than a restatement of the
objective.
Stroke Team:
• consideration of
rehabilitation/discharge needs
• PT
• OT
• Speech Therapy
• Nutrition
• Case Management
discharge of patient

G. Describe the contents
of GHS’s stroke clinical
pathway and how it
relates to external
agencies guidelines

Presentation of Case study
(patient admitted for TIA and
had a stroke while an inpatient
and received tPA)
Stroke Clinical Pathway
• ASA guidelines
• JCAHO disease specific
criteria:
• ED orders (tPA consideration,
administration)
• Admission orders
• Discharge orders
• Stroke Interdisciplinary Plan
of Care
• Stroke Pt/Family Education
Flowsheet
• Stroke Pt/Family Education
handbook
Post Test & Evaluations

TIME
FRAME
State the
time frame
for each
objective
50
minutes
7:00 - 7:50
7:00 7:10pm
7:10 7:20pm

LouNell
Eady, PT
Brigitte
King,
OTR/L
Karen
7:20 Arunakel
7:30pm
ST
Jennifer
7:30 Leckenby,
7:40pm
RD
Tammy
7:40 Edge,
7:50pm
BSN, RN
5 minutes Patti
7:50 - 7:55 Morgan,
RN
pm
30
Shannon
minutes
7:55 - 8:25 Sternberg,
BSN, RN,
pm
CNRN

5 minutes
8:25 –
8:30 pm
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PRESENT
ER
List the
Faculty for
each
objective.

METHODS
List learner’s
objectives in
behavioral terms
Didactic (to include
Case Study #1
interdisciplinary
treatment plan)
Video of swallow
study
Question/Answers
Group discussion

Didactic

Didactic
Handouts including
sample stroke clinical
pathway
Question/Answers

Appendix G
JCAHO Stroke Data Collection Tool
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